Cite
MLA Citation
Jiyoun Kim et al.. “Estimation of cost savings between 2011 and 2014 attributed to infliximab biosimilar in the South Korean healthcare market: real‐world evidence using a nationwide database.” International journal of rheumatic diseases, vol. 21, 2018, pp. 1227–1236. http://access.bl.uk/ark:/81055/vdc_100066533308.0x000016